Optimal primary surgical treatment for advanced epithelial ovarian cancer

The Cochrane Database of Systematic Reviews
Ahmed ElattarRaj Naik

Abstract

Ovarian cancer is the sixth most common cancer among women. In addition to diagnosis and staging, primary surgery is performed to achieve optimal cytoreduction (surgical efforts aimed at removing the bulk of the tumour) as the amount of residual tumour is one of the most important prognostic factors for survival of women with epithelial ovarian cancer. An optimal outcome of cytoreductive surgery remains a subject of controversy to many practising gynae-oncologists. The Gynaecologic Oncology group (GOG) currently defines 'optimal' as having residual tumour nodules each measuring 1 cm or less in maximum diameter, with complete cytoreduction (microscopic disease) being the ideal surgical outcome. Although the size of residual tumour masses after surgery has been shown to be an important prognostic factor for advanced ovarian cancer, it is unclear whether it is the surgical procedure that is directly responsible for the superior outcome that is associated with less residual disease. To evaluate the effectiveness and safety of optimal primary cytoreductive surgery for women with surgically staged advanced epithelial ovarian cancer (stages III and IV).To assess the impact of various residual tumour sizes, over a range between zero an...Continue Reading

References

Oct 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J GremS Vogl
Feb 1, 1991·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J R HardyS Tan
Apr 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P F ConteL Gallo
Mar 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J D HainsworthF A Greco
Feb 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G P SuttonC E Ehrlich
Mar 1, 1989·Gynecologic Oncology·D M GershensonR S Freedman
Apr 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G A OmuraR Mortel
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Apr 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J R RedmanT B Hakes
Jul 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W P McGuireJ Woodward
Oct 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A E TaylorC Fisher
Apr 1, 1993·Gynecologic Oncology·D L MarchettiM M Hreshchyshyn
Oct 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G B KristensenC Tropé
Apr 1, 1996·Obstetrics and Gynecology·P Benedetti-PaniciS Mancuso
Feb 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P F ConteA Rubagotti
Mar 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D V SkarlosG Fountzilas
Dec 31, 1997·Gynecologic Oncology·C VallejosW Rodriguez
Mar 4, 1999·Gynecologic Oncology·R E BristowB Y Karlan
Mar 10, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H BonnefoiM E Gore
Jan 7, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F M MuggiaJ M Small
Sep 14, 2000·Gynecologic Oncology·A L Covens

❮ Previous
Next ❯

Citations

Mar 8, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A González MartínA Poveda Velasco
Dec 12, 2012·Cancer Management and Research·Daniel L ChanTerence C Chua
Oct 30, 2014·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A Gonzalez-MartínL Vidal
Jun 25, 2015·Obstetrics and Gynecology International·Marianne J RuttenMarrije R Buist
May 13, 2017·Gynecologic Oncology·Kevin H EngJ Brian Szender
Jan 1, 2014·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·A FerreroN Biglia
Jan 4, 2017·Gynecologic Oncology·Roy KessousWalter H Gotlieb
Jan 10, 2018·Hormones & Cancer·Vladimir DjedovicTheodore J Brown
Jun 30, 2016·The Cochrane Database of Systematic Reviews·Rekha WuntakalGeoff Lane
Mar 2, 2013·The Cochrane Database of Systematic Reviews·Thuria Al RawahiKhadra Galaal
Feb 25, 2014·The Cochrane Database of Systematic Reviews·Marianne J RuttenMarrije Buist
Mar 27, 2015·The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS·Ching-Hui ChenWei-Min Liu
Mar 26, 2019·The Cochrane Database of Systematic Reviews·Roelien van de VrieMarrije Buist
Feb 25, 2015·Nature Reviews. Clinical Oncology·Alpa M NickAnil K Sood
May 9, 2013·Updates in Surgery·Salvatore Giovanni VitaleAntonio Cianci
Dec 24, 2018·The Oncologist·Ariane Mamguem KamgaTienhan Sandrine Dabakuyo-Yonli
Mar 5, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Luca FusoGuido Menato
Jan 24, 2019·Journal of Clinical Pathology·Aoife J McCarthyBlaise A Clarke
Nov 30, 2019·Hormone Molecular Biology and Clinical Investigation·Asmar JenniferAyoubi Jean Marc
Jun 12, 2018·Indian Journal of Surgical Oncology·Amrutha RamachandranDehannathparambil K Vijaykumar
May 18, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Meabh McNultyAndrew Dean
Oct 1, 2020·Journal of Ovarian Research·Alexandros LaiosChris Leach
Jan 10, 2016·The Cochrane Database of Systematic Reviews·Siriwan TangjitgamolAndrew Bryant
Jul 28, 2018·Nanomaterials·Tristan MangeolleFrédéric Marchal
Sep 29, 2019·Scientific Reports·Meshach Asare-WereheneBenjamin K Tsang
May 10, 2020·Journal of Experimental & Clinical Cancer Research : CR·Jing ZhangDan Jiang
Mar 30, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Mustafa Zelal MuallemJumana Muallem
Jun 17, 2020·Expert Opinion on Investigational Drugs·Giulio EvangelistiSimone Ferrero
Aug 14, 2020·Diagnostics·Pratistha KoiralaLinus Chuang
Apr 8, 2020·Frontiers in Oncology·Nastassja TerraneoJürgen Grünberg
Apr 1, 2020·International Journal of Environmental Research and Public Health·Chen-Yu HuangPeng-Hui Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.